What is ImmunityBio, Inc.'s shares (basic)?

ImmunityBio, Inc. (IBRX) reported shares (basic) of 1B in Q1 2026.

How has ImmunityBio, Inc.'s shares (basic) changed year-over-year?

ImmunityBio, Inc.'s shares (basic) increased by 20.4% year-over-year, from 853.2M to 1B.

What is the long-term trend for ImmunityBio, Inc.'s shares (basic)?

Over 4 years (2021 to 2025), ImmunityBio, Inc.'s shares (basic) has grown at a 23.5% compound annual growth rate (CAGR), from 1.5B to 3.6B.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

ImmunityBio, Inc. IBRX Shares (Basic)

Shares (Basic) at other companies

Johnson & JohnsonJNJ

2.4B+0.1%

Gilead SciencesGILD

1.2B-0.3%

Summit TherapeuticsSMMT

775.5M+5.1%

Immunovant, Inc.IMVT

——

Kymera TherapeuticsKYMR

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s shares (basic)?: ImmunityBio, Inc. (IBRX) reported shares (basic) of 1B in Q1 2026.
How has ImmunityBio, Inc.'s shares (basic) changed year-over-year?: ImmunityBio, Inc.'s shares (basic) increased by 20.4% year-over-year, from 853.2M to 1B.
What is the long-term trend for ImmunityBio, Inc.'s shares (basic)?: Over 4 years (2021 to 2025), ImmunityBio, Inc.'s shares (basic) has grown at a 23.5% compound annual growth rate (CAGR), from 1.5B to 3.6B.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.